|
|
|
|
|
27.11.25 - 09:15
|
Full-day Takeaway: HSI Closes at 25,945, Up 17 pts; HSTI Closes at 5,598, Down 20 pts; POP MART Up over 6%; HANSOH PHARMA, MTR CORPORATION, LEE & MAN PAPER, GLOBAL NEW MAT, ND PAPER Hit New Highs; Market Turnover Rises (AAStocks)
|
|
|
At close, HSI rose 17 pts or 0.1% to 25,945. HSTI dropped 20 pts or 0.4% to 5,598. HSCEI gained 2 pts or 0.0% to 9,164. Market turnover reached $204.73 billion.Active Heavyweights:BABA (09988.HK) closed at $150.6, down 2.7%XIAOMI (01810.HK) closed at $41.1, up 2.5%TENCENT (00700.HK) closed at $611.5, down 1.3%HKEX (00388.HK) clo......
|
|
|
27.11.25 - 01:15
|
CSPC feels the pain from sweeping cuts in drug prices (Bamboo Works)
|
|
|
The pharmaceutical giant is paying the price for its aggressively low bids in China's centralized drug tenders, as it shifts its focus from traditional to novel drugs Key Takeaway: By Molly Wen In business as in medicine, a remedy can take time to kick in. This is the challenge for Chinese drug giant CSPC.....
The post CSPC feels the pain from sweeping cuts in drug prices appeared first on Bamboo Works....
|
|
|
|
|
|
|
|
|
21.11.25 - 14:06
|
Innovent, first Chinese firm to market weight-loss drug, joins Hang Seng Index (SCMP)
|
|
|
Innovent Biologics will join the Hang Seng Index next month in the latest quarterly review as the compiler of the city's stock benchmark presses ahead with its plan to increase the number of constituents to 100.
The biotech firm, based in eastern Jiangsu province, has become the only new constituent of the blue-chip indicator, one month after it signed an US$11.4 billion outsourcing deal with Japan's Takeda Pharmaceuticals to co-develop and commercialise three specific investigational cancer......
|
|
|
|
|
21.11.25 - 06:42
|
3SBio spin-off Mandi banks on hair-loss and weight-loss drugs in Hong Kong IPO (SCMP)
|
|
|
Mandi, the Alibaba Health-backed consumer healthcare arm being spun off from mainland drug maker 3SBio, filed for an initial public offering in Hong Kong on Friday, betting that its market-leading minoxidil hair-loss products will attract investors.
The deal aims to tap into a red-hot Hong Kong market that has seen US$73 billion in equity capital market activity this year, a 232 per cent surge from the same period in 2024, according to data from the London Stock Exchange Group.
The company did......
|
|
|
|
|
20.11.25 - 05:30
|
Results: CSPC PHARMA 1-3Q NP RMB3.51B, Down 7.1% YoY (AAStocks)
|
|
|
CSPC PHARMA (01093.HK) announced its first three quarters results ended September 2025. The turnover declined 12.3% YoY to RMB19.891 billion. The net profit amounted to RMB3.511 billion, down 7.1% YoY. EPS was RMB30.72 cents. ~AAStocks Financial NewsWeb Site: www.aastocks.com...
|
|
|
|
|
|
|
17.11.25 - 05:00
|
Research: M Stanleys Latest Focus List for H Shrs (Table) (AAStocks)
|
|
|
Morgan Stanley released a China market strategy report, presenting its focus list for H-shares, Chinese ADRs, and A-shares:Stocks | Potential Upside from TPsAlibaba (BABA.US) | 26.7%Yangtze Power (600900.SH) | 21.6%CATL (300750.SZ) | 26.6%DUALITYBIO-B (09606.HK) | 60.5%ESPRESSIF (688018.SH) | 40.4%HKEX (00388.HK) | 16.1%HKT-SS (......
|
|
|
13.11.25 - 14:33
|
Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference (GlobeNewswire EN)
|
|
|
BOSTON, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that its senior leadership team will present at the prestigious Jefferies London Healthcare Conference....
|
|
|
13.11.25 - 09:15
|
Full-day Takeaway: HSI Closes at 27,073, Up 150 pts; HSTI Closes at 5,981, Up 47 pts; BABA Up over 3%; BEIGENE, CHINAHONGQIAO, CHINA LIFE, HENDERSON LAND, CITIC Hit New Highs; Market Turnover Rises (AAStocks)
|
|
|
At close, HSI rose 150 pts or 0.6% to 27,073. HSTI rose 47 pts or 0.8% to 5,981. HSCEI gained 60 pts or 0.6% to 9,599. Market turnover reached $270.67 billion.Active Heavyweights:BABA (09988.HK) closed at $162, up 3.3%PING AN (02318.HK) closed at $60.95, up 1.1%XIAOMI (01810.HK) closed at $43.5, down 0.5%MEITUAN (03690.HK) close......
|
|
|
13.11.25 - 05:30
|
Midday Takeaway: HSI Closes Midday at 26,766, Down 156 pts; HSTI Closes Midday at 5,888, Down 45 pts; BEIGENE Up over 6%; BEIGENE, CHINAHONGQIAO, MTR CORPORATION, HENDERSON LAND, GANFENGLITHIUM Hit New Highs (AAStocks)
|
|
|
At midday close, HSI dropped 156 pts or 0.6% to 26,766. HSTI dropped 45 pts or 0.8% to 5,888. HSCEI fell 61 pts or 0.6% to 9,477.Active Heavyweights:MEITUAN (03690.HK) closed at $100.4, down 1.4%BABA (09988.HK) closed at $154.9, down 1.2%TENCENT (00700.HK) closed at $649.5, down 1.1%XIAOMI (01810.HK) closed at $43.28, down 1%PIN......
|
|
|
13.11.25 - 00:36
|
Heidi sets sights on Hong Kong to expand North Asia healthcare footprint (SCMP)
|
|
|
Australian healthcare start-up Heidi plans to open its first North Asia office in Hong Kong this year, aiming to tap opportunities created by the city's acute doctor shortage and ageing population through its proprietary artificial intelligence platform.
Heidi co-founder and CEO Thomas Kelly said Hong Kong would serve as “an important market for us to unlock North Asia”.
“We think of China more broadly, but also surrounding countries in the region,” he said. “It will be one of our main areas of......
|
|
|
|
|
|